More than 20,000 FDA-regulated organizations, including 9 of the top 10 Pharmas and 7 of the top 10 CROs, are already using CoSign digital signatures in order to streamline operations, improve collaboration, support compliance and lower costs. In this whitepaper, you’ll get an inside look at how ten real-world life sciences organizations are using digital signatures to gain these benefits and more. You’ll also get a checklist of what to look for when evaluating a digital signature solution for your organization.
The majority of large CROs and Pharmas are using digital signatures to speed clinical site initiation, reduce site monitoring reporting costs, and improve audit efficiency. See how digital signatures enable these benefits and others by allowing key players in the clinical ecosystem (site personnel, IRBs, CROs, sponsors) to electronically sign and submit reports and other documents.